Connect with us

IT Industry

rideOS Launches New Devoted Platform to Power the Future of Ridehailing

GlobeNewswire

Published

on

Reading Time: 3 minutes

Transportation technology company expands its offering with new Ridehail API and Open-Source Apps

SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) — rideOS, a technology platform designed to accelerate the safe, global rollout of next-generation transportation fleets, today launched its new Ridehail Platform — including a Ridehail API and open-source mobile apps. The Ridehail API offers an easy way for automotive original equipment manufacturers (OEMs), autonomous vehicle (AV) companies, and transportation network companies (TNCs) to create and manage their own ridehailing network using rideOS’ underlying technology. The Ridehail API is available as a standalone backend API, or through new open-source driver and rider apps for iOS and Android. This is the first time a set of ridehailing applications have been open-sourced, allowing customers to easily rebrand or build new features on top of these new applications.

“Starting and maintaining a ridehailing network is unnecessarily complex. The plumbing it takes behind the scenes to route, dispatch and optimize a high-quality, ridehailing experience is tricky to build and time-consuming to maintain,” said Chris Blumenberg, rideOS chief technology officer and cofounder. “Our Ridehail API takes care of this plumbing, so autonomous companies and OEMs don’t have to, saving them time and money so they can get to market faster.”

The rideOS Ridehail Platform is the only routing and dispatching product that is base-map agnostic and compatible with both human-driven and autonomous vehicles. The Platform offers customers the flexibility to choose from a variety of integration points across the technology stack:

  • Open-Source Apps to quickly deploy fleets with virtually no integration time. Customers can easily rebrand the app by inserting their logo and swapping in their desired color palette.
  • Ridehail API to efficiently match riders with vehicles and manage trip state. This simple, easy-to-use API is the fastest way to incorporate all of rideOS’ underlying optimization and routing services into any customer’s existing app.
  • Fleet Planner API to build dynamic and optimal plans for fleets of vehicles including single rider and carpooling rides. This sophisticated optimization service is ideal for companies who already have basic dispatching services in an existing app, but would like to offer pooled trips or improve their fleet efficiency.
  • Routing API to get routes and accurate ETAs based on traffic conditions and the unique constraints of a given vehicle. The rideOS routing engine was specifically designed with AVs in mind, but is also compatible with human-driven vehicles. It offers customers the ability to define keep-out zones and restrict certain maneuvers based on the capabilities of their autonomous vehicle.

New rideOS partners leveraging the Ridehail Platform include Voyage, who is deploying the platform across their fleet of self-driving cars, and HERE, who has integrated their Mobile SDKs and Open Location Platform with rideOS’ Ridehail Platform — making it a seamless experience for existing HERE customers to utilize rideOS services.

“We’re excited to partner with rideOS and have seen great success in using the Ridehail Platform to power vehicle dispatch, routing, and trip state management in our communities,” said Voyage CEO and cofounder, Oliver Cameron. “The technology has made it seamless for us to optimize our fleets, so our team can focus on building a state-of-the-art, self-driving car without sacrificing additional time and resources.”

“We are thrilled to pair our Open Location Platform with rideOS’ Ridehail Platform and are fully committed to supporting their mission to accelerate the safe, global rollout of next generation transport,” said senior vice president and general manager of the Americas at HERE, Kirk Mitchell. “An autonomous world requires a level of accuracy and freshness that is orders of magnitude more than what had been traditionally accepted in ridehailing and dispatch. Together with rideOS, we are excited about redefining what a transportation platform can do as we prepare for the advent of full autonomy.”

The new Ridehail Platform shows rideOS’ current focus on creating bespoke ridehailing technologies. In the near future, the company expects to offer similar products for other use cases such as goods delivery, logistics, and industrial robotics.

For more information and to start using the platform today, visit https://rideos.ai.

About rideOS
rideOS designs and builds next generation marketplace and mapping services that can be utilized by ridehailing companies, OEMs, logistics providers, and governments to operate on-demand transportation services for both self-driving and human-operated fleets. rideOS’s mission is to accelerate the safe, global roll-out of next generation transport. For more information about rideOS, visit https://rideos.ai

PR Contact
Morgan Mathis for rideOS
rideos@highwirepr.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3f6e4a2b-4bef-48a0-a192-85e2159f22c2

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

IT Industry

Next-Generation Sequencing (NGS) Market 2019 Global Insights Type of Sequencing, Product Type, End User, Application, Competitive Landscape, Key Strategies & Growth Prospect: Orbis Research

GlobeNewswire

Published

on

Reading Time: 3 minutes

Orbisresearch.com has published “Next-generation Sequencing (NGS)-Growth, Trends, and Forecast (2019-2024)” research study to its database. Genetic Screening is the Segment Expected to Grow Fastest During the Forecast Period

Dallas, Texas, Aug. 24, 2019 (GLOBE NEWSWIRE) — As per the scope of this report, NGS is a technology in which millions of DNA strands can be sequenced through massive parallelization; this technique is also known as high throughput sequencing. The low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sanger’s sequencing method. NGS is, therefore, being used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, and agricultural and animal research, among others. Thus, the NGS market has transformed the genomics and molecular diagnostics landscape.

The major factors, such as increasing applications of NGS, speed, cost, and accuracy, efficient replacement for traditional technologies, and drug discovery applications demanding NGS technology are expected to drive the growth of the overall market.

Request a sample@https://www.orbisresearch.com/contacts/request-sample/3585369

The rapid speed, cost, and accuracy of the NGS technology help in the growth of the market. This is attained with the help of modern DNA sequencing technology, which has contributed to the sequencing of complete DNA sequences of numerous types and species of life. It is also found that NGS is significantly cheaper, quicker, and needs significantly lesser DNA, which helps in the overall growth of the market.

The NGS has the potential to accelerate the early detection of disorders and the identification of pharmacogenetics markers to customize its treatments.

There are various technological advancements in the field of medicine that are growing at a rapid pace and has led to the development of personalized medicine. There are a huge number of applications of next-generation sequencing in personalized medicine. Thus, the development of personalized medicine has opened many avenues for the application of NGS, which could accelerate the market growth.

The current market is also facing challenges, owing to the difficulty in management of large data and complications, associated with Big Data management. In addition, some of the ethical issues associated with whole-genome sequencing, coupled with the lack of awareness among people, are pulling back the growth of the market.

Key Market Trends

Genetic Screening is the Segment Under Application that is Expected to Grow Fastest During the Forecast Period

In genetic screening, the NGS is highly useful in identifying monogenic diseases with locus heterogeneity, such as blindness, deafness, movement disorders, mitochondrial disease, hereditary cancers, etc. Therefore, NGS has a large number of varied applications through genetic screening in multiple disorders, but their affordability and availability in high-income and low-income countries may differ a lot. The entire genomes are being mapped at affordable costs. Thus, steady growth is expected in the forecast period.

The NGS is also emerging as a powerful promising pathogen-detection method for infectious-disease diagnostics. It helps in the identification and genomic characterization of bacteria, fungi, parasites, and viruses, without the need for prior knowledge of a specific pathogen, directly from clinical specimens. As the diseases caused by infections are increasing in the less-developed countries, the NGS-powered diagnosis of these infections has become the most promising method to detect these infectious diseases. The NGS also has applications in personalized medicine that has started becoming a reality and has been under application by various biotechnology companies.

Browse the full report@https://www.orbisresearch.com/reports/index/next-generation-sequencing-ngs-growth-trends-and-forecast-2019-2024

Asia-Pacific is the Fastest-growing Market and is Expected to Follow the Same Trend over the Forecast Period

The market studied is expected to grow at the fastest pace in Asia-Pacific. The rising focus of the major market players is on delivering advanced, efficient NGS technology to the developing countries, in order to cater to the need for genomic medicines and whole genome sequencing for personalized medicine. In addition, the increasing adoption of NGS technology by the non-government and government bodies, along with increased investment of the private players, is expected to drive the Asian market.

Competitive Landscape
There are major biotech industries that are making large investments on evolving preventive vaccines and therapeutic vaccines that can stop or cure diseases, varying from viruses to cancers. The biotech industry, thus, uses the NGS to develop advanced diagnostic kits, in order to screen for pathological conditions and infectious diseases.

Direct purchase a single user copy@https://www.orbisresearch.com/contact/purchase-single-user/3585369

Major points from Table of Contents:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
 Continued…

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +91 895 659 5155
Email ID: enquiry@orbisresearch.com   
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch

Continue Reading

IT Industry

Cosmeceuticals Market to grow at 8.81% CAGR to hit $85 billion by 2024 – Global Insights on Emerging Trends, Product Type (Skin Care, Hair Care & Lip Care), Distribution Channel, Key Strategies & Growth Prospect: Orbis Research

GlobeNewswire

Published

on

Reading Time: 3 minutes

Orbisresearch.com has published “Cosmeceuticals Market-Growth, Trends and Forecasts (2019-2024)” research study to its database. Geographically, Asia-Pacific Dominates the Global Cosmeceuticals Market

Dallas, Texas, Aug. 24, 2019 (GLOBE NEWSWIRE) — Huge growth in necessary drugs to lessen the several skin problems and improve the appearance has increasingly supported the cosmeceuticals market growth since the past few years. Likewise, anti-ectoparasites and shampoos are the key cosmeceuticals products which are helping to increase consumer interest majorly in Europe and North America regions. In addition, rising demand for animal-friendly products is expected to contribute to the growth of the cosmeceuticals market over the forecast period.

The global cosmeceuticals market offers a wide range of products broadly categorised under skin care, hair care, lip care, and oral care. Also, the market covers the products available across distribution channels Supermarket/Hypermarkets, Convenience stores, online stores, speciality stores, others. Moreover, the study provides an analysis of the cosmeceuticals market in the emerging and established markets across the world, including North America, Europe, Asia-Pacific, South America, Middle East & Africa.

Request a sample@https://www.orbisresearch.com/contacts/request-sample/3586277

The global cosmeceuticals market is forecasted to reach USD 85 billion by 2024 growing at a CAGR of 8.81% during the forecast period (2019-2024).

– Countries, such as the United States, Canada, United Kingdom, Germany, and other European countries held a prominent share in the global cosmeceuticals market. China, India, and Vietnam present considerable growth opportunities for the market players, primarily due to the growing millennial population.
– Furthermore, raising awareness regarding cosmeceutical and cosmetics products, such as anti-aging, sun care, and hair care products, is expected to drive the growth potential in the near future. The introduction of new products with bio-active ingredients play a crucial role in driving the demand for cosmeceutical products across the world, especially in the Asia-Pacific region.

Key Market Trends

Growing Ageing Population
Consumers, especially the ageing population, are increasingly looking for methods and products to maintain and improve their appearance to look youthful and beautiful, more so with the rising awareness about anti-ageing products. The middle-aged people are increasingly witnessing ageing anxiety, due to the high prevalence of extrinsic signs of ageing. Anti-ageing skin products are known as cosmeceuticals, as they overlap the distinction between cosmetics and pharmaceuticals. Over the past two decades, declining fertility and mortality rate has resulted in a sustained rise in ageing population across the region, especially in China and Japan. Strong desire among men and women to retain youthful appearances has groomed and nurtured the cosmetic industry across the region.

Browse the full report@https://www.orbisresearch.com/reports/index/cosmeceutical-market-growth-trends-and-forecasts-2019-2024

Competitive Landscape
The most active companies in the market include key players, such as Procter & Gamble, Unilever, L’Oréal SA, Shiseido Co. Ltd, and The Estée Lauder Companies Inc. L’Oréal SA is one of the most active companies, with numerous brands offering a broad range of cosmeceuticals, across the world. The company has spent considerably on improving quality, product innovation in terms of ingredients, functionality, and packaging. Moreover, these active companies have adopted strategic acquisition as their key strategy, to increase their geographical presence and customer base.

Asia-Pacific Dominates the Global Cosmeceuticals Market
Though the term ‘cosmeceuticals’ started gaining momentum in China recently, it has now become one of the most preferred product categories in the country. Busier and stressful lifestyles of consumers in the country, as well as worsening environmental conditions, created more concern around skin conditions amid consumers who seek products for skin rejuvenation. This has led to an increase in sales of cosmeceuticals. Moreover, the population of Japan is among the most prolific consumers of cosmetics, placing it among the top five national markets for personal care products. From the viewpoint of not only size but also the trends and market demand, Japan can be regarded as a gateway to other Asian markets. Success in the Japanese market can raise product/brand profile and visibility, particularly in other Asian markets.

Direct purchase a single user copy@https://www.orbisresearch.com/contact/purchase-single-user/3586277

Major points from Table of Contents:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
 Continued…

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +91 895 659 5155
Email ID: enquiry@orbisresearch.com   
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch

Continue Reading

IT Industry

Carrier Screening Market Global Insights on Test Type, Disease Type, Restraints, Competitive Landscape and 2019 Top Trends: Orbis Research

GlobeNewswire

Published

on

Reading Time: 4 minutes

Orbisresearch.com has published “Carrier Screening Market-Growth, Trends, and Forecast (2019-2024)” research study to its database.

Dallas, Texas, Aug. 24, 2019 (GLOBE NEWSWIRE) — The major factors for the growth of the carrier screening market include the increasing emphasis on early disease detection and prevention, rising demand for personalized medicine, and increasing application of screening tests in genetic disorders, which is expected to experience a boost during the forecast period.

The earlier a disease is diagnosed, the more likely it can be cured or successfully managed. Treating the disease early could also make the disease easier to live with. Early disease detection helps people plan ahead, while they are still able to make important decisions regarding their health and support needs and on financial and legal matters. Genetic diseases, such as cystic fibrosis, sickle cell anemia, and Tay-Sachs disease, are inherited disorders. Carrier testing for such diseases can provide information about a couple’s risk of having a child with a genetic condition. Identification of the risk, prior to the onset of symptoms, is called predictive/presymptomatic testing. Many genetic disorders can be detected early during pregnancy. So, the consumer demand for safe and effective carrier tests is fueling the growth of this market. In addition, the adoption of carrier tests into regular clinical care offers a commercial advantage to the market. According to many studies, early detection of diseases can prevent them completely or at least decrease the complications of the diseases. Healthcare organizations in several countries are funding newborn screening to predict diseases, like cancers, which may occur later in adulthood.

Request a sample@https://www.orbisresearch.com/contacts/request-sample/3585427

Scope of the Report

As per the scope of the report, carrier screening is a type of genetic test to identify the autosomal recessive genetic disorders, before or during a pregnancy stage. Further, it helps in identifying a child with a genetic disorder. The market is segmented on the basis of screening test type (molecular screening test/biochemical screening test), disease type (cystic fibrosis, Tay-Sachs disease, sickle cell disease, gaucher disease, spinal muscular atrophy, and other autosomal recessive genetic disorders). In developed countries, such as the United States, Germany, and France, among others, the demand for screening tests to detect the risk of genetic diseases is driving the market’s growth.

Browse the full report@https://www.orbisresearch.com/reports/index/carrier-screening-market-growth-trends-and-forecast-2019-2024

Key Market Trends

Molecular Screening Test Segment by Test Type is Expected to Register Fastest Growth Rate during the Forecast Period

A molecular screening test identifies DNA mutations, which are variations in the genetic code that lead to decreased production of enzymes. It focuses on the mutations seen in one ethnic group. It involves a step-wise process of testing for common alleles, and if required, extensive gene analysis. Sequencing is a method of molecular screening, which is accomplished by reading across the DNA code of a specific gene to know if there are any known mutations. If the test results are negative, it reduces the chances that the individual is a carrier, however, it does not eliminate the chance of having a carrier gene, since it is possible that the mutation might not have been discovered yet through the current technology.

Some of the prominent recessive disorders for which molecular testing is beneficial are Canavan disease, Cystic fibrosis, GM1 gangliosidosis, spinal muscular atrophy, etc. With advancements in genetic analysis tools, like assays based on next-generation sequencing and microarray technologies, molecular diagnostics are revolutionizing the practice of medicine, by improving the prenatal and reproductive care, enabling earlier disease detection, and advancing the treatment for heritable diseases. There is an expansion of molecular testing, as it has the potential to increase testing accuracies through technical benefits for many targeted disorders that may not be suggested to biochemical testing.

North America accounted for the Largest Share in the Global Market

North America is found to hold a major share of the carrier screening market and is expected to show a similar trend over the forecast period, without significant fluctuations. Genetic disease is the leading cause of infant deaths in the United States, accounting for approximately 20% of the total annual infant mortality. Many advances in genomic medicine and technological platforms have made possible low-cost, pan?ethnic, expanded carrier screening that enables obstetric care providers to offer screening for over 100 recessive genetic diseases. However, the rapid integration of this genomic medicine into the routine obstetric practice has raised some concerns about the practical implementation of carrier testing. According to the Cystic Fibrosis Foundation, more than 30,000 people suffer from cystic fibrosis in the United States, and approximately 1,000 new cases of cystic fibrosis are diagnosed each year in the country. Thus, as the prevalence of genetic diseases is increasing every year, the usage of carrier screening is also expected to increase during the forecast period.

Direct purchase a single user copy@https://www.orbisresearch.com/contact/purchase-single-user/3585427

Competitive Landscape

The presence of major market players, such as Abbott, F. Hoffmann-La Roche AG, Cepheid (Danaher Corporation), Illumina Inc., and Thermo Fisher Scientific Inc, in turn, is increasing the overall competitive rivalry of the market. Most of the market players are expanding their technologies through acquisitions and partnerships. For instance, in January 2017, Philips and Illumina collaborated to offer the integrated genomics solutions for oncology.

Major points from Table of Contents:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
 Continued…

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +91 895 659 5155
Email ID: enquiry@orbisresearch.com   
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Business Wire40 mins ago

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Textron, Inc.

Business Wire40 mins ago

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Textron, Inc.

Business Wire2 hours ago

UBS Group AG and Merrill Lynch Are Being Investigated for Sales of Unsuitable Investments

IT Industry8 hours ago

Next-Generation Sequencing (NGS) Market 2019 Global Insights Type of Sequencing, Product Type, End User, Application, Competitive Landscape, Key Strategies & Growth Prospect: Orbis Research

IT Industry9 hours ago

Cosmeceuticals Market to grow at 8.81% CAGR to hit $85 billion by 2024 – Global Insights on Emerging Trends, Product Type (Skin Care, Hair Care & Lip Care), Distribution Channel, Key Strategies & Growth Prospect: Orbis Research

IT Industry10 hours ago

Carrier Screening Market Global Insights on Test Type, Disease Type, Restraints, Competitive Landscape and 2019 Top Trends: Orbis Research

IT Industry10 hours ago

Carrier Screening Market Global Insights on Test Type, Disease Type, Restraints, Competitive Landscape and 2019 Top Trends: Orbis Research

IT Industry10 hours ago

Influenza Diagnostics Market Estimated to grow at 6.83% to reach $731.97 Million by 2024- Global Insights on Test Type (Traditional Diagnostic Test and Molecular Diagnostic Assay), Restraints, Drivers and Future Trends: Orbis Research

Blockchain PR10 hours ago

Fantasy Sports Market Estimated to grow at 13.2% to reach $33200 Mn by 2025-Key Insights on Revenue (Value), Potential Application, Economic Fluctuations, Growth Rate and Future Trends: Orbis Research

Business Wire12 hours ago

FEDEX 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against FedEx Corporation

Follow our Tweets

Trending

Please turn AdBlock off